Furthermore, the obtained findings showed that PAI-1 could serve as a promising therapeutic target for enhancing the efficiency of cancer cachexia management in improving the treatment outcomes of GBM patients post-radiotherapy. The gene discussed is SERPINE1; the disease is glioblastoma.